XOMA ASKING COURT FOR 40% ROYALTIES FROM CENTOCOR’s CENTOXIN U.S. SALES; FDA RAISES ADDITIONAL CENTOXIN ISSUES; TOCOR II OFFERING NETS CENTOCOR $84 MIL.

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".